Unknown PHASE4 INTERVENTIONAL 2-arm NCT02264587

Effects and Mechanism of Mosapride Citrate on Diabetic Gastroparesis (MDGP)

Sponsor: Liangzhou Wei

Updated 6 times since 2017 Last updated: Oct 14, 2014 Started: Oct 31, 2014 Primary completion: Sep 30, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Diabetic Gastroparesis, this trial is ongoing. The trial is conducted by Liangzhou Wei and has accumulated 6 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2021 — Nov 2022 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Oct 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Liangzhou Wei
Sumitomo Pharma (Suzhou) Co., Ltd.

Data source: Qingdao University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.